NEW YORK (GenomeWeb) – N-of-One today said that it will provide OncoDNA with clinical interpretation services for its next-generation sequencing and other molecular tests for patients throughout Europe.

Belgium-based OncoDNA provides personalized medicine testing services for cancer patients. One of its tools is the OncoDEEP Clinical Plus test, which is an adapted version of the 400-gene Ion comprehensive cancer panel on the Ion Proton. It also offers a more focused targeted sequencing test, OncoDEEP Dx, using the 48-gene Ion AmpliSeq cancer panel.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.